Value Microcaps Zip Code Changers

[Bobwins]

Of course it's only the end of one phase II trial but arguably, the most important advantage that ATB-346 has against naproxen and aleve could be proven by a solid showing in this part of their phase II.

I like the fact that their trials can be pretty short compared to many drugs. They plan to test the ideal dosage in the next part of the phase II but it will be done before year end. Once that's done, seeking a partner that's big enough to challenge aleve in the US markets would start. Sounds like they don't plan to go phase III alone so the right partner would be crucial.